These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35124697)

  • 1. Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth.
    Jin Y; Pan Y; Zheng S; Liu Y; Xu J; Peng Y; Zhang Z; Wang Y; Xiong Y; Xu L; Mu K; Chen S; Zheng F; Yuan Y; Fu J
    Oncogene; 2022 Mar; 41(12):1752-1766. PubMed ID: 35124697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic-independent inhibition of cIAP1-mediated RIP1 ubiquitination by EGLN3.
    Fu J
    Cell Signal; 2016 Feb; 28(2):72-80. PubMed ID: 26612615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.
    Matsui C; Deng L; Minami N; Abe T; Koike K; Shoji I
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29695419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1.
    Suzuki J; Nakajima W; Suzuki H; Asano Y; Tanaka N
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1334-1340. PubMed ID: 27939888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity.
    Cai F; Yang X; Ma G; Wang P; Zhang M; Zhang N; Zhang R; Liang H; Nie Y; Dong C; Deng J
    Br J Cancer; 2024 Mar; 130(4):597-612. PubMed ID: 38184692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness.
    Chen M; Myers AK; Markey MP; Long W
    J Cell Physiol; 2019 Aug; 234(8):13220-13232. PubMed ID: 30569573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance.
    Li S; Rodriguez J; Li W; Bullova P; Fell SM; Surova O; Westerlund I; Topcic D; Bergsland M; Stenman A; Muhr J; Nistér M; Holmberg J; Juhlin CC; Larsson C; von Kriegsheim A; Kaelin WG; Schlisio S
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16997-17006. PubMed ID: 31375625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
    Yang F; Xie HY; Yang LF; Zhang L; Zhang FL; Liu HY; Li DQ; Shao ZM
    Autophagy; 2020 Jun; 16(6):1061-1076. PubMed ID: 32401166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperone-mediated Autophagy Regulates Cell Growth by Targeting SMAD3 in Glioma.
    Liu H; Yong Y; Li X; Ye P; Tao K; Peng G; Mo M; Guo W; Chen X; Luo Y; Lin Y; Qiu J; Zhang Z; Ding L; Zhou M; Yang X; Lu L; Yang Q; Xu P
    Neurosci Bull; 2022 Jun; 38(6):637-651. PubMed ID: 35267139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.
    Zheng ZG; Zhu ST; Cheng HM; Zhang X; Cheng G; Thu PM; Wang SP; Li HJ; Ding M; Qiang L; Chen XW; Zhong Q; Li P; Xu X
    Autophagy; 2021 Jul; 17(7):1592-1613. PubMed ID: 32432943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.
    Elkhadragy L; Alsaran H; Morel M; Long W
    J Biol Chem; 2018 Oct; 293(42):16193-16205. PubMed ID: 30166347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperone-mediated autophagy receptor modulates tumor growth and chemoresistance in non-small cell lung cancer.
    Ichikawa A; Fujita Y; Hosaka Y; Kadota T; Ito A; Yagishita S; Watanabe N; Fujimoto S; Kawamoto H; Saito N; Yoshida M; Hashimoto M; Minagawa S; Hara H; Motoi N; Yamamoto Y; Ochiya T; Araya J; Kuwano K
    Cancer Sci; 2020 Nov; 111(11):4154-4165. PubMed ID: 32860290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LUBAC promotes angiogenesis and lung tumorigenesis by ubiquitinating and antagonizing autophagic degradation of HIF1α.
    Jin Y; Peng Y; Xu J; Yuan Y; Yang N; Zhang Z; Xu L; Li L; Xiong Y; Sun D; Pan Y; Wu R; Fu J
    Oncogenesis; 2024 Jan; 13(1):6. PubMed ID: 38272870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.
    Bogucka K; Marini F; Rosigkeit S; Schloeder J; Jonuleit H; David K; Schlackow M; Rajalingam K
    Cancer Gene Ther; 2021 May; 28(5):359-374. PubMed ID: 33070159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.
    Fu J; Taubman MB
    J Biol Chem; 2010 Mar; 285(12):8927-35. PubMed ID: 20089853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.
    Long W; Foulds CE; Qin J; Liu J; Ding C; Lonard DM; Solis LM; Wistuba II; Qin J; Tsai SY; Tsai MJ; O'Malley BW
    J Clin Invest; 2012 May; 122(5):1869-80. PubMed ID: 22505454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.
    Elkhadragy L; Alsaran H; Long W
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability.
    Fu J; Menzies K; Freeman RS; Taubman MB
    J Biol Chem; 2007 Apr; 282(17):12410-8. PubMed ID: 17344222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluation of the Role of Extracellular Signal-Regulated Kinase 3 in Perinatal Survival and Postnatal Growth Using New Genetically Engineered Mouse Models.
    Soulez M; Saba-El-Leil MK; Turgeon B; Mathien S; Coulombe P; Klinger S; Rousseau J; Lévesque K; Meloche S
    Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30642949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways.
    Rodriguez J; Pilkington R; Garcia Munoz A; Nguyen LK; Rauch N; Kennedy S; Monsefi N; Herrero A; Taylor CT; von Kriegsheim A
    Cell Rep; 2016 Mar; 14(11):2745-60. PubMed ID: 26972000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.